•  
  •  
 

Turkish Journal of Chemistry

DOI

10.3906/kim-1504-65

Abstract

Numerous efficient synthetic methodologies have been elaborated for the synthesis of $\beta $-blockers since the introduction of propranolol (a beta-blocker) in 1968. In this review, focus is placed on the more concise asymmetric and bioenzymatic synthetic approaches attempted towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol).

Keywords

Beta-blockers, cardiovascular activity, antiglaucoma agent, biotransformations

First Page

193

Last Page

224

Included in

Chemistry Commons

Share

COinS